GeneDx Holdings Corp. WGS
48.16 USD +0.87 (+1.83%)
As ofNov 18, 2026, 9:33 AM EST
46.47 Day range 48.16
34.51 52-week range 167.51
- YTD
- -62.97%
- 1 year
- -62.06%
News
benzinga.com GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $482.324M Est GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $482.324 million estimate.
defenseworld.net GeneDx Holdings Corp. $WGS Stock: Aberdeen Group plc Lowers Position Aberdeen Group plc reduced its position in GeneDx Holdings Corp. (NASDAQ: WGS) by 29.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The…
businesswire.com GeneDx to Participate in Upcoming Investor Conferences GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx to Participate in Upcoming Investor Conferences.benzinga.com GeneDx To Present New Research At The National Society Of Genetic Counselors Conference, November 11-14; Data Show 62% Of Patients With Pathogenic Or Likely Pathogenic Findings Had Results Associated With Opportunities To Inform Medical Management New research analyzing exome and genome sequencing results from more than 300,000 patients found that 62% of patients with pathogenic or likely pathogenic findings (62,459 of 101,390) had results…
benzinga.com Groupon Posts Downbeat Q3 Results, Joins GeneDx Holdings, Qualys And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session Groupon plunged 20% premarket after missing quarterly earnings and sales estimates, while Digital Turbine, Daqo and others also traded lower.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings…
benzinga.com Why Sanmina Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket Sanmina surges 18.8% after strong Q4 results and above-estimate FY27 guidance; Rubico leads gainers, while Microvast plunges 48.5%.benzinga.com BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $85 BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $90 to $85.
benzinga.com GeneDx Holdings Q3 2026 Earnings Call Transcript GeneDx Holdings (NASDAQ:WGS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $482.324M Est GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $482.324 million estimate.
benzinga.com Range Resources, Xtend AI Robotics, Oruka Therapeutics And Other Big Stocks Moving Higher On Monday U.S. stocks rose; Dow gained 350 points. Range Resources jumped 15% on EQT acquisition, while Surgery Partners and others posted sharp gains.
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…benzinga.com GeneDx Plans To Enhance Its Genome Testing Portfolio With Long-Read Whole Genome Sequencing Long-read sequencing analyzes longer stretches of DNA to identify complex genetic variation, including certain structural variants and repeat expansions that can go undetected by traditional…
